SCHEMBL18776490

SCHEMBL18776490

CC[C@]1(CO)O[C@@H](c2cnc3c(C)nc(N)nn23)[C@H](F)[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18193387 0.95 — —
SCHEMBL18193388 0.92 — —
SCHEMBL15257356 0.91 — —
SCHEMBL15257372 0.89 — —
SCHEMBL15257378 0.86 CSNK1D (0.30) —
SCHEMBL18776492 0.85 — —
SCHEMBL15259033 0.84 — —
SCHEMBL15257346 0.84 — —
SCHEMBL15257340 0.83 — —
SCHEMBL18193389 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170114086-A1 2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. 2017-04-27 — — US disclosed
US-9481704-B2 2′-substituted carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC. (US) 2016-11-01 — — US disclosed
Send feedback